Company Overview and News

 
Medadvisor exceeds 1 million connected patients, is represented in 50% of pharmacies

2018-04-06 proactiveinvestors.com.au
Medadvisor Ltd (ASX:MDR), a prominent digital medication management company, has reached a key milestone of 1 million connected patients.
Upvote Downvote

 
MedAdvisor to take health-tech strategy to investors

2017-10-20 proactiveinvestors.com.au
MedAdvisor Ltd (ASX:MDR) has positioned itself in the rapidly growing health-tech sector, with a focus on a medication management platform.
Upvote Downvote

 
MedAdvisor teams with U.S. health monitoring company

2017-05-29 proactiveinvestors.com.au
MedAdvisor (ASX:MDR) has signed an agreement to integrate its platform with U.S. health monitoring company iHealth Labs’ mobile healthcare solutions.
Upvote Downvote

 
MedAdvisor Ltd to accelerate user acquisition via new partnership

2016-10-07 proactiveinvestors.com.au
MedAdvisor Ltd (ASX:MDR) has partnered with national not-for-profit health association Osteoporosis Australia to offer its platform to a highly relevant patient population. The MedAdvisor app works by connecting to pharmacy dispensing systems to automatically retrieve medication records of patients and show reminders to ensure correct medication use. The new partnership will see the MedAdvisor platform communicated to Osteoporosis Australia’s community (including over 150,000 visitors to the Osteoporosis Australia website).
Upvote Downvote

 
MedAdvisor Ltd to accelerate user acquisition via new partnership

2016-10-07 proactiveinvestors.com.au
MedAdvisor Ltd (ASX:MDR) has partnered with national not-for-profit health association Osteoporosis Australia to offer its platform to a highly relevant patient population. The MedAdvisor app works by connecting to pharmacy dispensing systems to automatically retrieve medication records of patients and show reminders to ensure correct medication use. The new partnership will see the MedAdvisor platform communicated to Osteoporosis Australia’s community (including over 150,000 visitors to the Osteoporosis Australia website).
Upvote Downvote

 
MedAdvisor Ltd launches new tool for Australians living with diabetes

2016-08-25 proactiveinvestors.com.au
MedAdvisor Ltd (ASX:MDR) has launched a new tool that allows people living with diabetes to order their consumable products and ensure accurate supply in pharmacy. The facility has been launched in collaboration with the national diabetes organisation, Diabetes Australia. The National Diabetes Services Scheme (NDSS), funded by the Australian Government and administered by Diabetes Australia, provides subsidised diabetes consumable products.
Upvote Downvote

 
MedAdvisor Ltd to assist glaucoma patients with medication adherence app

2016-08-15 proactiveinvestors.com.au
MedAdvisor Ltd (ASX:MDR) has signed an agreement with Glaucoma Australia Inc, to help improve medication adherence in patients living with glaucoma. The MedAdvisor app works by connecting to pharmacy dispensing systems to automatically retrieve medication records of patients and show reminders to ensure correct medication use. As part of the collaboration, Glaucoma Australia will become a MedAdvisor Health Association Partner and will encourage patients living with glaucoma to utilise the MedAdvisor platform.
Upvote Downvote

 
MedAdvisor Ltd partners with Bristol-Myers Squibb

2016-07-01 proactiveinvestors.com.au
MedAdvisor Ltd (ASX:MDR) is collaborating with Bristol-Myers Squibb Australia, to deliver a new patient engagement and education program. The 12-month patient engagement program will generate additional revenue for the PEP platform. Bristol-Myers Squibb Company is a global biopharmaceutical company. The agreement recognises that the platform assists patients in medication management.
Upvote Downvote

 
MedAdvisor Ltd rings in strong growth for digital medication manager

2016-06-29 proactiveinvestors.com.au
MedAdvisor Ltd (ASX:MDR) is eyeing strong growth in its pharmacy related medication adherence app platform, with 180,000 users now using the platform. This is a growth of 10% per month from the March quarter and patients per pharmacy have increased 35% from 75, to reach 108 today. The leading Australian medication reminder app connects to pharmacy dispensing systems to automatically retrieve medication records of patients and show reminders to ensure correct medication use.
Upvote Downvote

 
MedAdvisor Ltd is helping people manage their medication

2016-05-05 proactiveinvestors.com.au
MedAdvisor Ltd (ASX:MDR) has a mobile app and web service that helps people manage their medication. Poor medication adherence and medication management is one of the biggest addressable health issues. It leads to nearly US$500 billion of avoidable healthcare costs internationally. The app, called MedAdvisor, is used by 30% of Australia’s pharmacies and rated by over 140,000 active patients as the best rated apps in the App/Google Play stores.
Upvote Downvote

 
Appendix 3B

2016-04-18 asx.com.au
Upvote Downvote

Related Articles

LPCN: Lipocine Inc Analysis and Research Report

2018-04-23 - Asif

Overview Lipocine is a specialty pharmaceutical company focused on applying its oral drug delivery technology for the development of pharmaceutical products in the area of men’s and women’s health. The company's proprietary delivery technologies are designed to improve patient compliance and safety through orally available treatment options. The company's primary development programs are based on oral delivery solutions for poorly bioavailable drugs. Lipocine has a portfolio of proprietary product candidates designed to produce favorable pharmacokinetic (“PK”) characteristics and facilitate lower dosing requirements, bypass first-pass metabolism in certain cases, reduce side effects, and eliminate gastrointestinal interactions that limit bioavailability. The company's lead product candidate, TLANDO™, is an oral testosterone replacement therapy (“TRT”) and is currently under review by the United States Food and Drug Administration (“FDA”) with a Prescription Drug User Fee Act (“...

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...